Correlation Between Novo Nordisk and PROQR THERAPEUTICS
Can any of the company-specific risk be diversified away by investing in both Novo Nordisk and PROQR THERAPEUTICS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Novo Nordisk and PROQR THERAPEUTICS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Novo Nordisk AS and PROQR THERAPEUTICS EO 04, you can compare the effects of market volatilities on Novo Nordisk and PROQR THERAPEUTICS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Novo Nordisk with a short position of PROQR THERAPEUTICS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Novo Nordisk and PROQR THERAPEUTICS.
Diversification Opportunities for Novo Nordisk and PROQR THERAPEUTICS
-0.71 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Novo and PROQR is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Novo Nordisk AS and PROQR THERAPEUTICS EO 04 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PROQR THERAPEUTICS and Novo Nordisk is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Novo Nordisk AS are associated (or correlated) with PROQR THERAPEUTICS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PROQR THERAPEUTICS has no effect on the direction of Novo Nordisk i.e., Novo Nordisk and PROQR THERAPEUTICS go up and down completely randomly.
Pair Corralation between Novo Nordisk and PROQR THERAPEUTICS
Assuming the 90 days trading horizon Novo Nordisk is expected to generate 3.33 times less return on investment than PROQR THERAPEUTICS. But when comparing it to its historical volatility, Novo Nordisk AS is 4.11 times less risky than PROQR THERAPEUTICS. It trades about 0.06 of its potential returns per unit of risk. PROQR THERAPEUTICS EO 04 is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 143.00 in PROQR THERAPEUTICS EO 04 on September 2, 2024 and sell it today you would earn a total of 197.00 from holding PROQR THERAPEUTICS EO 04 or generate 137.76% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Novo Nordisk AS vs. PROQR THERAPEUTICS EO 04
Performance |
| Timeline |
| Novo Nordisk AS |
| PROQR THERAPEUTICS |
Novo Nordisk and PROQR THERAPEUTICS Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Novo Nordisk and PROQR THERAPEUTICS
The main advantage of trading using opposite Novo Nordisk and PROQR THERAPEUTICS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Novo Nordisk position performs unexpectedly, PROQR THERAPEUTICS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PROQR THERAPEUTICS will offset losses from the drop in PROQR THERAPEUTICS's long position.| Novo Nordisk vs. Superior Plus Corp | Novo Nordisk vs. NMI Holdings | Novo Nordisk vs. Origin Agritech | Novo Nordisk vs. SIVERS SEMICONDUCTORS AB |
| PROQR THERAPEUTICS vs. REVO INSURANCE SPA | PROQR THERAPEUTICS vs. SPARTAN STORES | PROQR THERAPEUTICS vs. PICKN PAY STORES | PROQR THERAPEUTICS vs. Fast Retailing Co |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |